drugset / Trial / NCT03219437
A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the safety and efficacy of risankizumab to methotrexate in participants with moderate to severe plaque psoriasis.
Timeline
- Start
- 2018-07-30
- Primary completion
- 2021-11-26
- Completion
- 2021-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | — | — |
| Subject | Risankizumab | Monoclonal antibody | — | Subcutaneous |